Circulation · 2001 · 107 citations · 31 references
cTnT predicts poorer clinical outcomes, lower rates of postprocedural TIMI 3 flow, and more severely compromised myocardial perfusion despite normal epicardial flow. Thus, a cTnT-positive patient may require more aggressive adjunctive therapy when treated by percutaneous coronary intervention. The impact of preexisting or evolving microvascular dysfunction and the effect of therapies that target myocardial perfusion require further prospective evaluation.
31
Fibrinolytic Therapy Trialists' Collaborative Group · The Lancet · 1994 · 2.3K citations
Thrombosis, Cardiovascular Disease, Clinical Epidemiology +15